Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions. Check out our latest thought leadership pieces below.

Moving Beyond the Rear-View Mirror: Why Real-Time Behavioral Signals are the Next Frontier for Healthcare CTV

June 19, 2026

Heartbeats vs. Heatmaps: Why the Future of Pharma Media is Human

March 31, 2026

In an era of rampant automation and AI disruption, how do we keep the "human" in healthcare? We explore the growing tension between the science of automation and the art of human connection.

The health union bubble creates a funnel of people emerging.

The “Buy Now” Era of Pharma: Navigating Pharma’s Direct-to-Patient Revolution

March 24, 2026

Learn how the shift to Direct-to-Patient (DTP) models is transforming online health communities into "digital front doors" that turn trusted community engagement into high-intent care.

The Authority Gap: Why Trust is Pharma’s Only Real Currency in 2026

March 18, 2026

By bridging the gap between DTC and HCP silos and prioritizing medically validated "safe spaces," brands can move beyond the vanity metrics of reach to secure the high-value trust that drives patient action and clinical validation.

5 Ways to Make Your Pharma Marketing More Personal

January 20, 2021

Break through the noise and reach and engage people during their unique health journey with our tips to help personalize your pharma marketing strategies.

The Positive Impact of CFTR Modulators: a Year-Over-Year Comparison

December 22, 2020

Current CFTR modulator usage increased from nearly half of respondents in 2019, when three modulators were approved, to 68% in 2020.

Migraine Patient-Reported Survey Data

December 16, 2020

New Health Union survey data show patients experience a very high number of symptoms and triggers, reinforcing that migraine is “more than just a headache.”

Inflammatory Bowel Disease Patient-Reported Survey Data

December 11, 2020

New survey data from Health Union reveals that half of respondents living with inflammatory bowel disease experience symptoms 15+ days per month.

Healthcare Industry Thought Leadership

Contact